Total
0
Shares
MyFiziq (ASX:MYQ) - CEO & Executive Director, Vlado Bosanac - The Market Herald
CEO & Executive Director, Vlado Bosanac
Source: MyFiziq
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • MyFiziq (MYQ) has created a disruptive tech platform to revolutionise the medical imaging market, and the business is now changing its name to reflect its global strategy
  • After laying the foundations for an upcoming listing on the NASDAQ, MyFiziq is now rebranding to Advanced Human Imaging (AHI)
  • What's more, the company has already reserved its new ticker code on both the ASX and NASDAQ exchanges
  • CEO Vlado Bosanac says the new name is the natural next step for the company as it transforms from a fitness app into a true competitor in the field of medical technology
  • Importantly, MyFiziq says it is well-funded to hit its goals ahead of a successful NASDAQ listing — meaning there is no new capital raise on the horizon
  • By changing its name to Advanced Human Imaging ahead of its NASDAQ listing, MyFiziq is emerging as a prime ASX example of a transformation story
  • Investors who join the fray now have the opportunity to witness a game-changer in the medical imaging field first-hand

MyFiziq (MYQ) has created a disruptive tech platform to revolutionise the medical imaging market, and the business is now changing its name to reflect its global strategy.

The body scanning and medical imaging specialist has already laid the foundations for an upcoming listing on the NASDAQ.

Now, MyFiziq is rebranding to Advanced Human Imaging (AHI). What's more, the company has already reserved its new ticker code on both the ASX and the NASDAQ exchanges as it breaks the mould in the lucrative medical imaging sector.

Co-founder and CEO Vlado Bosanac said the new name is the natural next step for the company as it transforms from a primarily fitness-focussed app into a true competitor in the field of medical technology.

"Changing our name from MyFiziq to Advanced Human Imaging is in line with the business' transformation from a body-tracking app to a company with full-fledged medical imaging capabilities and applications," Vlado said.

"It's an important next step for the company as we work towards listing on the NASDAQ, where we will have access to the kind of support and high-quality investment that can only be offered by the world's leading tech exchange," he said.

The name change was overwhelmingly approved by shareholders at an extraordinary general meeting (EGM) today, where the MYQ management team outlined its international strategy.

Shareholders at the EGM approved the name change by almost 57 million votes for to just 3,600 votes against.

Strong balance sheet, shrewd management

Importantly, MyFiziq said it has enough funding to keep moving forward as it achieves its key goals ahead of a successful NASDAQ listing.

"The company is well-funded to meet all of our key objectives as we take this next transformative step for the business," Vlado said.

"We have a strong management team and sufficient resources to keep hitting goals across the board."

As such, MyFiziq reaffirmed that there are no plans for an upcoming capital raise, with all the resources needed for its NASDAQ listing already available.

Crucial imaging from the phone in your pocket

MyFiziq's technology gives users accurate body measurements from the convenience of their phone.

Using nothing more than a smartphone, users can measure the human form across 12,000 data points and analyse key vital markers with an effectiveness usually only available from a medical clinic.

The tech was initially used to track body measurements, weight-to-height ratios and total body fat with up to 97 per cent accuracy, providing crucial assistance in a user's weight loss journey.

The tech has evolved, however, to read biometric markets associated with a range of chronic health conditions like cardiovascular disease, obesity and Type 2 diabetes.

On top of this, the tech can detect subtle skin colour changes to capture key vital signs that signal blood pressure, cardiac load, heart rate, risk of stroke and more.

And with global partnerships with the likes of Canadian skin disease specialist Triage Technologies, Australian biotech Biomorphik, and Chinese medicine and body-scanning company Tinjoy Biotech, the MYQ tech has even further to run.

Now, by changing its name to Advanced Human Imaging ahead of its listing on the NASDAQ, the business is emerging as a prime ASX example of a transformation story.

Investors that supported the company early on have already been richly rewarded, with MyFiziq shares gaining some 2200 per cent since March 2020.

But the best is yet to come for Advanced Human Imaging. Investors who join the fray now have the opportunity to witness a game-changer in the medical imaging field first-hand.

MYQ by the numbers
More From The Market Herald
The Market Herald Video

" Sovereign Metals (ASX:SVM) and rutile: the $4B commodity you’ve never heard of

Rutile is a mineral investors have probably never heard of, but up-and-coming player Sovereign Metals (SVM) says it’s something they’ll certainly want to
The Market Herald Video

" Macarthur Minerals (ASX:MIO) and the future of the Great Southern mining network

With the exception of actually pulling stuff out of the ground, transport is perhaps the biggest hurdle facing a successful mining operation.
Billion Dollar Business Series: Mayur Resources (ASX:MRL) rewrites the playbook for junior explorers

" Billion Dollar Business Series: Mayur Resources (ASX:MRL) rewrites the playbook for junior explorers

Mayur Resources (MRL) has rewritten the playbook for junior explorers with its unique and innovative corporate strategy.
Advanced Human Imaging (ASX:AHI): a unique opportunity in the massive telehealth market

" Advanced Human Imaging (ASX:AHI): a unique opportunity in the massive telehealth market

The global healthcare market is in the midst of a significant transformation as major tech innovations drive the demand for digital health.